“Unfolding Parkinson’s Disease Through the Microbiome-Gut-Brain Axis”

Key Points

• Cognitive decline occurs alongside shifts in the microbiome composition, impacting neurodegeneration.
• Key findings associate the gut-brain axis with increased inflammation and altered metabolites in Parkinson’s disease.
• Observational analysis evaluates connections between gut microbiome changes and cognitive deterioration over time.
• Recognizing microbiome influence highlights potential therapeutic avenues for managing Parkinson’s disease.